Related Experiment Video
Updated: Jul 4, 2025

Heterokaryon Technique for Analysis of Cell Type-specific Localization
Published on: March 11, 2011
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma
Anja Deutzmann1, Delaney K Sullivan1, Renumathy Dhanasekaran1,2
1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, 94305, USA.
Abstract:
The MYC oncogene is often dysregulated in human cancer, including hepatocellular carcinoma (HCC). MYC is considered undruggable to date. Here, we comprehensively identify genes essential for survival of MYChigh but not MYClow cells by a CRISPR/Cas9 genome-wide screen in a MYC-conditional HCC model. Our screen uncovers novel MYC synthetic lethal (MYC-SL) interactions and identifies most MYC-SL genes described previously. In particular, the screen reveals nucleocytoplasmic transport to be a MYC-SL interaction. We show that the majority of MYC-SL nucleocytoplasmic transport genes are upregulated in MYChigh murine HCC and are associated with poor survival in HCC patients. Inhibiting Exportin-1 (XPO1) in vivo induces marked tumor regression in an autochthonous MYC-transgenic HCC model and inhibits tumor growth in HCC patient-derived xenografts. XPO1 expression is associated with poor prognosis only in HCC patients with high MYC activity. We infer that MYC may generally regulate and require altered expression of nucleocytoplasmic transport genes for tumorigenesis.
Insights
We identified genes crucial for survival in high MYC liver cancer cells, revealing nucleocytoplasmic transport as a key vulnerability. Targeting Exportin-1 (XPO1) showed promise for treating MYC-driven hepatocellular carcinoma (HCC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The MYC oncogene is frequently dysregulated in human cancers, including hepatocellular carcinoma (HCC).
- MYC is currently considered an undruggable cancer target.
- Identifying vulnerabilities in MYC-driven cancers is critical for therapeutic development.
Purpose of the Study:
- To identify genes essential for the survival of MYC-high cells in HCC.
- To uncover novel synthetic lethal interactions with MYC.
- To investigate the therapeutic potential of targeting identified MYC-synthetic lethal interactions.
Main Methods:
- Conducted a genome-wide CRISPR/Cas9 screen in a MYC-conditional HCC model.
- Analyzed gene expression and survival data in murine HCC and human HCC patient cohorts.
- Evaluated the in vivo efficacy of Exportin-1 (XPO1) inhibition in preclinical HCC models.
Main Results:
- Discovered novel MYC synthetic lethal (MYC-SL) interactions, with nucleocytoplasmic transport emerging as a key vulnerability.
- Found that most MYC-SL nucleocytoplasmic transport genes are upregulated in MYC-high murine HCC and linked to poor patient survival.
- Demonstrated significant tumor regression and growth inhibition by targeting XPO1 in vivo in HCC models.
- Observed that XPO1's prognostic significance in HCC is restricted to patients with high MYC activity.
Conclusions:
- Nucleocytoplasmic transport represents a critical dependency and potential therapeutic target in MYC-driven HCC.
- XPO1 inhibition shows therapeutic promise for hepatocellular carcinoma with high MYC expression.
- MYC may broadly regulate and necessitate altered nucleocytoplasmic transport gene expression for tumorigenesis.
More Related Videos
Related Concept Videos
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Directionality of Nuclear Transport
Regulation of Nuclear Protein Sorting
Nuclear Export of mRNA
Nuclear Localization Signals and Import

